Back to Search
ANTHONY CARDILLO, MD
MD
Clinical Pathology/Laboratory Medicine Physician
NPI: 1992365712IndividualAccepts Medicare
Specialties, Licenses & Credentials
Clinical Pathology/Laboratory Medicine PhysicianPrimary
Pathology — Clinical Pathology/Laboratory Medicine
Code: 207ZP0105X
22-642(NY)
CMS Specialties
PrimaryPATHOLOGY
Education
OTHER
Class of 2019
Research & Publications (20)
Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic features.
PMID 19182679·Anticancer Drugs·2009
5-case
Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy.
PMID 18941889·Breast Cancer Res Treat·2009
3-trial
Skeletal muscle gene expression after myostatin knockout in mature mice.
PMID 19509079·Physiol Genomics·2009
7-preclinical
Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure.
PMID 19562480·Breast Cancer Res Treat·2009
8-other
Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: prognostic implications of EGFR immunoreactivity.
PMID 18839307·Breast Cancer Res Treat·2009
3-trial
Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy.
PMID 17986623·Ann Oncol·2008
8-other
Topoisomerase IIalpha gene status and prediction of pathological complete remission after anthracycline-based neoadjuvant chemotherapy in endocrine non-responsive Her2/neu-positive breast cancer.
PMID 18456496·Breast·2008
8-other
Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activity.
PMID 18941458·Br J Cancer·2008
8-other
Preoperative concurrent chemo- and endocrine therapies for women with large operable breast cancer expressing steroid hormone receptors.
PMID 18595702·Breast·2008
8-other
Factors that predict early treatment failure for patients with locally advanced (T4) breast cancer.
PMID 18506176·Br J Cancer·2008
8-other
Expression of Brugmansia candida Hyoscyamine 6beta-Hydroxylase gene in Saccharomyces cerevisiae and its potential use as biocatalyst.
PMID 18505565·Microb Cell Fact·2008
8-other
Low-dose aspirin for the prevention of venous thromboembolism in breast cancer patients treated with infusional chemotherapy after insertion of central vein catheter.
PMID 17578607·Support Care Cancer·2007
8-other
Adjuvant treatment for young women with early breast cancer.
PMID 17912178·Minerva Ginecol·2007
6-review
HER2 status in early breast cancer: relevance of cell staining patterns, gene amplification and polysomy 17.
PMID 17855075·Eur J Cancer·2007
8-other
Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension.
PMID 17154392·Liver Transpl·2007
3-trial
Role of fluorodeoxyglucose positron emission tomography in the staging of patients with breast cancer candidated to surgery.
PMID 17043097·Ann Oncol·2007
8-other
Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer.
PMID 16978400·BMC Cancer·2006
3-trial
Prolonged clinical benefit with metronomic chemotherapy in patients with metastatic breast cancer.
PMID 16940806·Anticancer Drugs·2006
3-trial
Structural properties of planar graphs of urban street patterns.
PMID 16906914·Phys Rev E Stat Nonlin Soft Matter Phys·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 327 E 64TH ST
NEW YORK, NY 10065 - Phone
- (800) 525-2225
Quick Facts
- NPI
- 1992365712
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 7
- Publications
- 20
Are you this provider?
Claim Your Profile